Correlation Between Gmo Alternative and Evaluator Moderate

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Gmo Alternative and Evaluator Moderate at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gmo Alternative and Evaluator Moderate into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Gmo Alternative Allocation and Evaluator Moderate Rms, you can compare the effects of market volatilities on Gmo Alternative and Evaluator Moderate and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gmo Alternative with a short position of Evaluator Moderate. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gmo Alternative and Evaluator Moderate.

Diversification Opportunities for Gmo Alternative and Evaluator Moderate

-0.39
  Correlation Coefficient

Very good diversification

The 3 months correlation between Gmo and Evaluator is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding Gmo Alternative Allocation and Evaluator Moderate Rms in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Evaluator Moderate Rms and Gmo Alternative is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gmo Alternative Allocation are associated (or correlated) with Evaluator Moderate. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Evaluator Moderate Rms has no effect on the direction of Gmo Alternative i.e., Gmo Alternative and Evaluator Moderate go up and down completely randomly.

Pair Corralation between Gmo Alternative and Evaluator Moderate

Assuming the 90 days horizon Gmo Alternative is expected to generate 24.83 times less return on investment than Evaluator Moderate. But when comparing it to its historical volatility, Gmo Alternative Allocation is 1.56 times less risky than Evaluator Moderate. It trades about 0.01 of its potential returns per unit of risk. Evaluator Moderate Rms is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  906.00  in Evaluator Moderate Rms on August 31, 2024 and sell it today you would earn a total of  209.00  from holding Evaluator Moderate Rms or generate 23.07% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Gmo Alternative Allocation  vs.  Evaluator Moderate Rms

 Performance 
       Timeline  
Gmo Alternative Allo 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Gmo Alternative Allocation has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong technical and fundamental indicators, Gmo Alternative is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Evaluator Moderate Rms 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Evaluator Moderate Rms are ranked lower than 12 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong primary indicators, Evaluator Moderate is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Gmo Alternative and Evaluator Moderate Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Gmo Alternative and Evaluator Moderate

The main advantage of trading using opposite Gmo Alternative and Evaluator Moderate positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gmo Alternative position performs unexpectedly, Evaluator Moderate can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evaluator Moderate will offset losses from the drop in Evaluator Moderate's long position.
The idea behind Gmo Alternative Allocation and Evaluator Moderate Rms pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Complementary Tools

Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Insider Screener
Find insiders across different sectors to evaluate their impact on performance